Guanfacine extended-release for cannabis use disorder: a pilot feasibility trial.

Conclusions: G-XR is a feasible treatment for CUDs, and should be evaluated further in an efficacy trial.
PMID: 31339797 [PubMed - as supplied by publisher]

Source: The American Journal of Drug and Alcohol Abuse - July 23, 2019 Category: Addiction Authors: Dakwar E, Mahony A, Choi CJ, Pavlicova M, Brooks D, Mariani JP, Levin FR Tags: Am J Drug Alcohol Abuse Source Type: research